Intellectual property
Netherlands: Covid-19: Emergency Act temporarily amends Dutch Patents Act
12 August 2020 - Posted by: Isabel Rutten
In June 2020, the Dutch House of Representatives passed an Emergency Act to temporarily amend the Dutch Patent Act, allowing patent holders and applicants more time to secure and preserve their patents. Before the introduction of the Emergency Act, the Covid-19 pandemic may have affected companies that owned patents or were in the process of › Read More
17 April 2020 - Posted by: Rafi Allos
An Arrow declaration is a form of discretionary relief granted by UK courts declaring that a product or process would have lacked novelty, or been obvious, at a specific point in time. In contrast to declarations of non-infringement, an Arrow declaration can, in certain circumstances, be sought to achieve commercial certainty in relation to a › Read More
Podcast: How to protect IP as part of a digital transformation strategy
16 April 2020 - Posted by: Nigel Parker
Digitalisation is transforming businesses at an ever-increasing rate. No matter the sector, technologies like cloud computing, the Internet of Things, AI and Blockchain are enabling streamlining of operations, new distribution channels and better customer insights. Digital transformation is also creating new strategic imperatives as “digital natives” take market share from traditional industries. Partners Mark Ridgway › Read More
China’s life sciences industry remains opportune despite Covid-19 coronavirus
01 April 2020 - Posted by: David Shen
While the novel Covid-19 coronavirus is at the top of the agenda for businesses around the world, and for good reason, it is creating challenges for medical and healthcare systems and signalling fundamental change across the life sciences industry. Activity in China’s life sciences market remains high as one of the few sectors to › Read More
Evalve v Edwards – Review of competing public interests in grant of final injunctions
24 March 2020 - Intellectual Property - Posted by: Marjan Noor
The issue of whether public interest considerations can be relied upon against the grant of a final injunction, or for a carve out in the injunction, is a very live one in disputes in relation to innovative medical devices and pharmaceuticals. In this decision, Edwards argued that, although its PASCAL product used to treat mitral › Read More